What is the main business of CMK Pharma?

The main business activity of CMK Pharma focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 18, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Koszykowa 54, 00-675 Warszawa.

What is the share capital?

The share capital of the company is PLN 45,000 (approx. $12,156).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

In 2024, the company generated total revenue of $1,607, representing a decrease of 38.9% compared to 2023.

No, in 2024 the company was not profitable, reporting a net loss of $153,008. For comparison, in 2023 the loss was $166,523, meaning the company reduced its loss by 12.7%.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $120,618 in 2024, representing 91% of all operating expenses.

CMK Pharmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-03-18

Share capital

45,000.00 PLN

Registered address

ul. Koszykowa 54, 00-675 Warszawa, Poland

Financials

Revenue history

Filing timeliness

No financial statement for 2025 – the filing deadline has passed.

2025not filed
202414/07/2025
202309/07/2024
202212/07/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 1.61kMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD -153.01kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 132.57kMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 10.02kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Rafał Franciszek Szabłowski – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board is authorized individually to make declarations of will on behalf of the company. If the management board is multi-member, two members of the management board, or a member of the management board acting jointly with a commercial proxy, are authorized to make declarations of will on behalf of the company.

Supervisory board

Agnieszka Dyszczyk – Supervisory Board Member

Bartosz Norbert Lis – Supervisory Board Member

Wojciech Iwaniuk – Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Centrum Medycyny Konopnej S.A.	900	$12,155.59	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-04-07.

BNP Paribas Bank Polska
88 1600 1462 1749 2138 5000 0001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Black & Whitesp. z o.o.	$154,866.36	polonus.pl
Osteoprofsp. z o.o.	$72,065.80	osteoprof.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Filicosp. z o.o.	$11,710.75	filico.eu
Get Ready Wheelchairssp. z o.o.	$9,842.54	getreadywheelchairs.com
Jacek Waksmundzki Trust 2S.K.A.	$5,769.53	trust.pl
Optimedussp. z o.o.	$1.00	optimedus.pl